We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

1 hedge funds and large institutions have $3K invested in GW Pharmaceuticals Plc American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 294 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 297 → 1 (-296)

100% less funds holding in top 10

Funds holding in top 10: 21 → 0 (-21)

100% less capital invested

Capital invested by funds: $5.23B → $3K (-$5.23B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 294

Holders
1
Holders Change
-296
Holders Change %
-99.66%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-21
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
294
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
-$456M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$325M
3
HI
HBK Investments
Texas
-$292M
4
FCM
Farallon Capital Management
California
-$277M
5
GCL
Glazer Capital LLC
New York
-$212M
Name Holding Trade Value Shares
Change 		Change in
Stake
E
76
Ergoteles
New York
– -$7.18M -33,102 Closed
State Street
77
State Street
Massachusetts
– -$6.86M -31,611 Closed
QOP
78
Quinn Opportunity Partners
Virginia
– -$6.72M -31,000 Closed
BSCM
79
Berry Street Capital Management
United Kingdom
– -$6.51M -30,000 Closed
MCM
80
Moore Capital Management
New York
– -$6.51M -30,000 Closed
Geode Capital Management
81
Geode Capital Management
Massachusetts
– -$6.03M -27,797 Closed
KC
82
Kellner Capital
New York
– -$5.42M -25,000 Closed
PAMU
83
Pictet Asset Management (UK)
United Kingdom
– -$422K -24,612 Closed
Commonwealth Equity Services
84
Commonwealth Equity Services
Massachusetts
– -$4.88M -22,517 Closed
CU
85
CQS (US)
New York
– -$4.69M -21,629 Closed
JG
86
Jefferies Group
New York
– -$4.69M -21,618 Closed
Stifel Financial
87
Stifel Financial
Missouri
– -$4.49M -20,683 Closed
KPF
88
K2 Principal Fund
Ontario, Canada
– -$4.34M -20,000 Closed
CIM
89
Cambria Investment Management
California
– -$4.26M -19,647 Closed
Barclays
90
Barclays
United Kingdom
– -$4.24M -19,524 Closed
PCM
91
Prelude Capital Management
New York
– -$4.05M -18,653 Closed
AIMCA
92
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$3.99M -18,400 Closed
RJFSA
93
Raymond James Financial Services Advisors
Florida
– -$3.97M -18,318 Closed
RG
94
Rathbones Group
United Kingdom
– -$3.95M -18,231 Closed
NAM
95
Nexpoint Asset Management
Texas
– -$3.94M -18,161 Closed
VanEck Associates
96
VanEck Associates
New York
– -$3.91M -18,047 Closed
Bank of New York Mellon
97
Bank of New York Mellon
New York
– -$3.84M -17,705 Closed
HA
98
Havens Advisors
New York
– -$3.69M -17,000 Closed
LOAMU
99
Lombard Odier Asset Management (USA)
New York
– -$3.69M -17,000 Closed
CCM
100
Crabel Capital Management
California
– -$3.4M -15,673 Closed
2 3
4
5 6

GWPH Hedge Fund Activity: Q2 2021 in Review

1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2021, worth a combined $3K — down 100% from $5.23B a quarter earlier.

Sellers outnumbered buyers: 294 funds closed out of GWPH and 0 opened new positions — a net loss of 294 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Pentwater Capital Management, exiting entirely with an estimated $456M sold.

  • 1 institutional investor held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2021, down from 297 in Q1 2021.
  • Funds reported $3K of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2021 and 294 closed out, a net change of -294 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2021 was Pentwater Capital Management, an estimated $456M sold.

Based on aggregated 13F filings for Q2 2021.